Cryoport announces new strategic partnership with syneos health to advance cell & gene therapies

Partnership to provide cell and gene industry integrated solution including cryoport's integricell™ platform, and supply chain services nashville, tenn. , jan. 18, 2023 /prnewswire/ -- cryoport, inc. (nasdaq: cyrx) ("cryoport"), a leading global provider of innovative temperature-controlled supply chain solutions to the life sciences industry focused on the pharmaceutical and cell and gene therapy markets, today announced a new strategic partnership with syneos health® (nasdaq: synh), the only fully integrated biopharmaceutical solutions organization purpose-built to accelerate customer success.
CYRX Ratings Summary
CYRX Quant Ranking